These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 11817586)

  • 1. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding fragment of fibronectin in human articular cartilage in culture.
    Yasuda T; Poole AR; Shimizu M; Nakagawa T; Julovi SM; Tamamura H; Fujii N; Nakamura T
    Arthritis Rheum; 2003 May; 48(5):1271-80. PubMed ID: 12746900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
    Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
    Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes.
    Forsyth CB; Pulai J; Loeser RF
    Arthritis Rheum; 2002 Sep; 46(9):2368-76. PubMed ID: 12355484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM; Elliott SF; Cawston TE
    Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments.
    Homandberg GA; Hui F
    Arch Biochem Biophys; 1996 Oct; 334(2):325-31. PubMed ID: 8900407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COOH-terminal heparin-binding fibronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44.
    Yasuda T; Kakinuma T; Julovi SM; Yoshida M; Hiramitsu T; Akiyoshi M; Nakamura T
    Rheumatology (Oxford); 2004 Sep; 43(9):1116-20. PubMed ID: 15213332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
    Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
    Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis.
    Tchetina EV; Kobayashi M; Yasuda T; Meijers T; Pidoux I; Poole AR
    Matrix Biol; 2007 May; 26(4):247-58. PubMed ID: 17306969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
    Billinghurst RC; Dahlberg L; Ionescu M; Reiner A; Bourne R; Rorabeck C; Mitchell P; Hambor J; Diekmann O; Tschesche H; Chen J; Van Wart H; Poole AR
    J Clin Invest; 1997 Apr; 99(7):1534-45. PubMed ID: 9119997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
    Stanton H; Ung L; Fosang AJ
    Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
    Tchetina EV; Squires G; Poole AR
    J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes.
    Hui A; Min WX; Tang J; Cruz TF
    Arthritis Rheum; 1998 May; 41(5):869-76. PubMed ID: 9588740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.